Searching map area
Eighteen-month safety analysis of offspring breastfed by mothers receiving glatiramer acetate therapy for relapsing multiple sclerosis โ€“ COBRA study
? TBD
scientific article published in 2022
2022
Join to rate
Ratings 0
Nobody has rated this yet. Be the first!
Lists 0
Join to rate
Abstract

Safety data on disease-modifying therapies (DMTs) for relapsing multiple sclerosis (RMS) during breastfeeding are limited.

Authors Andrea Ines Ciplea, Anna Kurzeja, Sandra Thiel, Sabrina Haben, Jessica Alexander, Evelyn Adamus
Volume Vol. 28, No. 10, pp. 1641-1650
Reading
DOI10.1177/13524585221083982 PubMed
Instance of
Scholarly article
Author
Kerstin Hellwig
Published in
Multiple Sclerosis Journal
License
Creative Commons Attribution-NonCommercial 4.0 International
References
Wikidata